251 related articles for article (PubMed ID: 26030337)
1. Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes.
Kurzrock R; Giles FJ
Cell Cycle; 2015; 14(14):2219-21. PubMed ID: 26030337
[TBL] [Abstract][Full Text] [Related]
2. Implementing Genome-Driven Oncology.
Hyman DM; Taylor BS; Baselga J
Cell; 2017 Feb; 168(4):584-599. PubMed ID: 28187282
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
Subbiah V; Kurzrock R
Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
[TBL] [Abstract][Full Text] [Related]
5. [Implementing next-generation sequencing for precision hematology/oncology].
Maeda T
Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
[TBL] [Abstract][Full Text] [Related]
6. Precision diagnostics: integration of tissue pathology and genomics in cancer.
Sharma S; George P; Waddell N
Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
[TBL] [Abstract][Full Text] [Related]
7. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
8. The possibility of clinical sequencing in the management of cancer.
Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
[TBL] [Abstract][Full Text] [Related]
9. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Cheng F; Hong H; Yang S; Wei Y
Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
[TBL] [Abstract][Full Text] [Related]
10. Unique molecular landscapes in cancer: implications for individualized, curated drug combinations.
Wheler J; Lee JJ; Kurzrock R
Cancer Res; 2014 Dec; 74(24):7181-4. PubMed ID: 25326492
[TBL] [Abstract][Full Text] [Related]
11. Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.
Miles G; Rae J; Ramalingam SS; Pfeifer J
Semin Oncol; 2015 Oct; 42(5):713-23. PubMed ID: 26433552
[TBL] [Abstract][Full Text] [Related]
12. Precision medicine in pediatric oncology: Lessons learned and next steps.
Mody RJ; Prensner JR; Everett J; Parsons DW; Chinnaiyan AM
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27748023
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
Ziogas DE; Kyrochristos ID; Roukos DH
Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
[No Abstract] [Full Text] [Related]
14. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
15. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Miller FA; Hayeems RZ; Bytautas JP; Bedard PL; Ernst S; Hirte H; Hotte S; Oza A; Razak A; Welch S; Winquist E; Dancey J; Siu LL
Eur J Hum Genet; 2014 Mar; 22(3):391-5. PubMed ID: 23860039
[TBL] [Abstract][Full Text] [Related]
16. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of next-generation sequencing in precision oncology.
Hux A; Lewis A; Sachwitz D; Gregory T
JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
[TBL] [Abstract][Full Text] [Related]
18. Exploiting rare driver mutations for precision cancer medicine.
Scholl C; Fröhling S
Curr Opin Genet Dev; 2019 Feb; 54():1-6. PubMed ID: 30844512
[TBL] [Abstract][Full Text] [Related]
19. Precision Oncology: Who, How, What, When, and When Not?
Schwartzberg L; Kim ES; Liu D; Schrag D
Am Soc Clin Oncol Educ Book; 2017; 37():160-169. PubMed ID: 28561651
[TBL] [Abstract][Full Text] [Related]
20. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
